The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.

Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced its first major market access ...

GoodRx has been hit with a series of antitrust class actions in California and Rhode Island federal courts challenging the ...

GoodRx and pharmacy benefit managers CVS Caremark, Express Scripts, MedImpact and Navitus Health Solutions are facing class-action lawsuits accusing them of colluding to super press reimbursements to ...

The two other cases name them as well as PBMs CVS Caremark (NYSE:CVS), Express Scripts, which is owned by Cigna (NYSE:CI), ...

When asked about restrictions on supportive care medications, a spokesman for CVS Caremark, one of the nation’s largest ...

CVS Pharmacy Inc. and the former president of Cigna Corp.'s Express Scripts asked a federal judge to amend an injunction ...

According to the company, effective January 1, 2025, cyclosporine ophthalmic solution 0.1% (Vevye) will be included on key ...

Express Scripts said the legal action was "reckless ... chief legal officer at Cigna. CVS Caremark said that preventing PBMs from negotiating drug prices will only benefit pharma companies ...

There is a tendency to overlook the multiple factors and stakeholders that contributed to the Rx opioid crisis. This includes ...